Clinical Trials Browser

Interventional × Antibodies × 1 year × Clear all

Neuroblastoma

NCT06451497 2026-04-02

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

BreastGastrointestinalGenitourinaryHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Prostatic Neoplasms, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Triple Negative Breast Neoplasms

NCT03280563 2025-11-10

MORPHEUS HR+BC

Phase 1/2 Completed

144 enrolled 25 charts

Breast

Breast Neoplasms

NCT00199862 2025-07-04

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

Phase NA Completed

30 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07008703 2025-06-06

Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain

Phase 1/2 Recruiting

132 enrolled

Cancer Pain

Clinical Trials

MiniVan

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

MORPHEUS HR+BC

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain